TREM1 and breast carcinoma: In tumor tissue sections from breast cancer (BRCA), LC, and KIRC, regions containing TREM1+ PMN-MDSCs exhibited significantly enhanced immunosuppressive activity, suggesting a role for TREM1+ PMN-MDSCs in promoting immunosuppression within the TME (Fig. 6A).